Method for preparing pyrrolidone
US-2024132925-A1 · Apr 25, 2024 · US
US9567595B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9567595-B2 |
| Application number | US-201514707231-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 8, 2015 |
| Priority date | May 5, 2010 |
| Publication date | Feb 14, 2017 |
| Grant date | Feb 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering recombination inside or outside of a cell using isolated and/or purified polypeptides and/or nucleic acid sequences from Alicyclobacillus acidocaldarius.
Opening claim text (preview).
What is claimed is: 1. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 90% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 2. The vector of claim 1 , wherein the polypeptide has activity at or below about pH 8. 3. The vector of claim 1 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 4. The vector of claim 1 , wherein the polypeptide has activity as a DNA adenine methylase. 5. A vector comprising a first nucleic acid sequence encoding the polypeptide of SEQ ID NO: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 6. The vector of claim 5 , wherein the first nucleic acid sequence comprises SEQ ID NO: 2892. 7. A method of modulating or altering nucleic acid methylation in a cell, the method comprising: providing the vector of claim 1 to a cell; and expressing the first nucleic acid sequence to produce the polypeptide. 8. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8. 9. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius. 10. The method according to claim 7 , wherein the polypeptide is glycosylated, pegylated, or otherwise post-translationally modified. 11. The method according to claim 7 , wherein the polypeptide has activity as a DNA adenine methylase. 12. The method according to claim 7 , wherein the polypeptide has activity at or below about pH 8. 13. The method according to claim 7 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 14. A method of modulating or altering nucleic acid methylation, the method comprising: providing an isolated or purified polypeptide having at least 90% sequence identity to SEQ ID No: 2891 to a nucleotide sequence in which adenine demethylation is desired. 15. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8. 16. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius. 17. The method according to claim 14 , wherein the purified or isolated polypeptide is glycosylated, pegylated, or otherwise post-translationally modified. 18. The method according to claim 14 , wherein the purified or isolated polypeptide has activity as a DNA adenine methylase. 19. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at or below about pH 8. 20. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at a temperature at or above about 50 degrees Celsius. 21. The vector of claim 5 , wherein the polypeptide has activity at or below about pH 8. 22. The vector of claim 5 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 23. The vector of claim 5 , wherein the polypeptide has activity as a DNA adenine methylase. 24. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 99% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 25. The vector of claim 24 , wherein the polypeptide has activity at or below about pH 8. 26. The vector of claim 24 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 27. The vector of claim 24 , wherein the polypeptide has activity as a DNA adenine methylase.
Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00) · CPC title
derived from bacteria {or Archaea} · CPC title
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title
Methyltransferases (general) (2.1.1.) · CPC title
Site-specific DNA-methyltransferase (adenine-specific) (2.1.1.72) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.